Sartaj Tabassum
Sartaj Tabassum
Professor
  • :91 -9358255791

Department of Chemistry
Muslim UniversityAligarh
India

Education

1981 B.Sc

Agra University

Chemistry, Botany, Zoology

1983 M.Sc

Agra University

Chemistry

  1985 MPhil Ph.D

Aligarh Muslim University

Chemistry

1988 B.Sc

Agra University

Chemistry, Botany, Zoology

 

Biography

Prof. Sartaj Tabassum is working as Professor in the Department of Chemistry, Aligarh Muslim University, Aligarh. He was awarded Senor Research Fellowship (1988) and Research Associateship (1991) by CSIR New Delhi and in 1994 he was appointed as lecturer in the department of chemistry, Aligarh Muslim University. He has published 101 papers in the journals of international repute. He has presented his research work and delivered invited lectures in conferences/symposia. He is a life member of ICC, CRSI ,ISCB, DNA Society of India and American Nano Society. He has successfully guided 16 Ph.D and 4 M.Phil students. He has successfully completed many research schemes granted by TWAS, Italy, CSIR, New Delhi, DBT, Govt. of India. As a distinguished Scientist, Prof. Tabassum was awarded Overseas Associateship award in 2005 by DBT, Govt of India. He has signed several MoU and joint research collaboration with University of Camerino UNICAM, Italy, USM Malaysia and USTC Hefei, China. He has visited many countries for academic pursuit particularly, China, USA, Italy as fellow, visiting Professor and for the international conferences. Prof. Tabassum is working in the area of medicinal inorganic chemistry.

Research Interest

His research interest includes design and synthesis of heterobimetallic complexes which have potential to act as cancer chemotherapeutics

Professional Activities:

2004-2005 Biotechnology Overseas Associateship Award (Ministry of Science and Technology, Department of Biotechnology, Govt of India)
1991 - 1993   Research Associate (CSIR, New Delhi)
1988 - 1991   Senior Research Fellow, (CSIR, New Delhi)
1987 - 1988   Research Fellow, (CSIR, New Delhi)

 

Publications

  1. Synthesis and spectroscopic characterization of diorganotin(IV) complexes of N'–(4–hydroxypent–3–en–2–ylidene)isonicotinohydrazide: Chemotherapeutic potential validation by in vitro interaction studies with DNA/HSA, DFT, molecular docking and cytotoxic activity, Shipra Yadav, Musheer Ahmad, Mohd. Usman, Farukh Arjmand, Sartaj Tabassum* RSC Advances (Accepted 2015).
  2. Nuclear blebbing of biologically active organoselenium compound towards human cervical cancer cell (HeLa): In vitro DNA/HSA binding, cleavage and cell imaging studies. Masood Ahmad Rizvi, Mehvash Zaki, Mohd. Afzal, Manoj Mane, Manjeet Kumar, Bhahwal Ali Shah, Saurabh Srivastav, Saripella Srikrishna, Ghulam Mustafa Peerzada, Sartaj Tabassum, European Journal of Medicinal Chemistry, 90 (2015) 876-888
  3. A multifunctional molecular entity CuII–SnIV heterobimetallic complex as a potential cancer chemotherapeutic agent: DNA binding/cleavage, SOD mimetic, topoisomerase Iα inhibitory and in vitro cytotoxic activities, Sartaj Tabassum, Ahmad Asim, Rais Ahmad Khan, Farukh Arjmand, Dhivya Rajakumar, Perumalsamy Balaji, Mohammad Abdulkader Akbarshad,  RSC Adv., 2015,5, 47439-47450.
  4. 3.Synthesis and crystal structure determination of a mononuclear cobalt(II) complex derived from 4-(pyridin-4-ylmethoxy)-benzoic acid: evaluation of the DNA/protein interaction and photo-induced pBR322 DNA cleavage, Sartaj Tabassum, Ruchi Singh, Mehvash Zaki, Musheer Ahmad,   Mohd. Afzal, RSC Adv., 2015,5, 35843-35851 
  5. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells, Imtiyaz Yousuf,  Farukh Arjmand, Sartaj Tabassum,  Loic Toupet,  Rais Ahmad Khan, Maqsood Ahmad Siddiqui, Dalton Trans., 2015,44, 10330-10342 
  6. Organo-tin Antitumor Compounds: Their Present Status in Drug Development and Future Perspectives.Farukh Arjmand, Sabiha Parveen, Sartaj Tabassum, Claudio Pettinari, Inorg. Chim. Acta, 423, 26–37 (2014).                  
  7. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies. Sartaj Tabassum, Mehvash Zaki, Mohd. Afzal, Musheer Ahmad, Saurabh Srivastav, Saripella Srikrishna and Farukh Arjmand, Eur. J. Med. Chem., 83, 141−154 (2014).              
  8. Organometallic Ruthenium(II) Scorpionate as Topo II inhibitor; in vitro Binding Studies with DNA, HPLC Analysis and its Anticancer Activity. Rais Ahmad Khan, Farukh Arjmand, Sartaj Tabassum, Magda Monari, Fabio Marchetti, Claudio  Pettinari, J. Organomet. Chem. 71, 47−58, (2014).                
  9. Exploration of glycosylated–organotin(IV) complexes as anticancer drug candidates., Sartaj Tabassum, Shipra Yadav, Farukh Arjmand, Inorg. Chim. Acta, 423,  38–45, (2014).  
  10. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: In vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines, Sartaj       Tabassum, Mehvash Zaki, Mohd. Afzal, Farukh Arjmand, European Journal of  Medicinal Chemistry, 74, 3 2014,  509-523.
  11. New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII–SnIV complex as potential topoisomerase II inhibitor: In vitro DNA binding, cleavage and cytotoxicity against human cancer  cell lines,  Sartaj Tabassum, Mohd Afzal, Farukh Arjmand, European Journal of Medicinal Chemistry, 74, 3 2014, 694-702.
  12. Synthesis and structure elucidation of a cobalt(II) complex as topoisomerase I inhibitor: In vitro DNA binding, nuclease and RBC hemolysis , Musheer Ahmad, Mohd. Afzal, Sartaj Tabassum, Bożena Kalińska, Jerzy    Mrozinski, Parimal K. Bharadwaj European Journal of Medicinal Chemistry, 74, 3, 2014, 683-693
  13. DNA binding, docking studies, artificial nuclease activity and in vitro cytotoxicity                 of newly synthesized steroidal 1H–pyrimidines Shamsuzzaman, Ayaz Mahmood Dar, Sartaj Tabassum, Mehvash Zaki, Yusuf    Khan, Aamir Sohail, Manzoor Ahmad Gatoo, Comptes Rendus Chimie,  17, 4,                2014,  359-369
  14. Heterobimetallic O–Vanillin functionalized complexes: In vitro DNA binding validation, cleavage activity and molecular docking studies of CuII–SnIV analogs  Sartaj Tabassum, Shipra Yadav, Iqbal Ahmad, J. Organomet. Chem. 752, 17–24 (2014).
  15. Carbohydrate linked organotin(IV) complexes as human topoisomerase Iα       inhibitor and their antiproliferative effects against the human carcinoma cell line     Rais Ahmad Khan, Shipra Yadav, Zahid Hussain, Farukh Arjmand and Sartaj       Tabassum  Dalton Trans., 2014,43, 2534–2548.
  16. Chiral heterobimetallic complexes targeting human DNA–topoisomerase Iα. Sartaj Tabassum, Ahmad Asim, Rais Ahmad Khan, Zahid Hussain, Saurabh Srivastav, Saripella Srikrishna and Farukh Arjmand, (2013) Dalton. Trans. 42,                 16749–16761 (2013).
  17. Synthesis and mechanistic insight of glycosylated CuII / NiII–Sn2IV heterobimetallic DNA binding agents: Validation of a specific CuII–Sn2IV chemotherapeutic agent for human leukemic cell line K–562.  Sartaj Tabassum, Shipra Yadav, Farukh Arjmand, J. Organomet. Chem.    745–746, 226–234 (2013).
  18. New modulated design and synthesis of quercetin–CuII/ZnII–Sn2IV scaffold as   anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo–I activity. Sartaj Tabassum, Mehvash Zaki, Mohd. Afzal, Farukh Arjmand, Dalton               Trans. 2013, 42, 10029.
  19. A Chloro–Bridged Heterobimetallic (η6–Arene) ruthenium–Organotin Complex as an Efficient Topoisomerase Iα Inhibitor Sartaj Tabassum, Rais Ahmad Khan, Asim Ahmad, Rita Kakkar, Deepti Gupta, Vivek Bagchi                Organometallics, 42, 3390–3401, 2013
  20. Mixed–ligand Cu(II)–vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity. S. Tabassum, S. Amir,  F. Arjmand, C. Pettinari, F. Marchetti, N. Masciocchi, G. Lupidi, R. Pettinari, Eur J Med Chem. 60, 216–232 (2013)
  21. Design and synthesis of (S)– and (R)–enantiomers of [4–(2–hydroxy–1 phenylethylimino)pent–2–ol]dimethyltin(iv) and 2,2–dimethyl–4–phenyl–1,3,2–oxazastannolidine: in vitro antitumor activity against human tumor cell lines and        in vivo assay of (S)–enantiomers. F. Arjmand, F. Sayeed, S. Parveen, S. Tabassum, A. S. Juvekar,  S. M. Zingde, Dalton Trans. 42, 3390–3401 (2013).
  22. Synthesis and characterization of copper(II) and zinc(II)–based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding     profile, cleavage and antimicrobial activity. S. Tabassum, A. Asim, F. Arjmand, M. Afzal, V. Bagchi, Eur J Med Chem. 58, 308–316 (2012).
  23. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNA. F. Arjmand, A. Jamsheera, M. Afzal, S. Tabassum,  Chirality.; 24, 977–86. (2012 )
  24. New heterobimetallic Cu(II)–Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer  cell lines. S. Tabassum, M. Afzal, F. Arjmand, J Photochem Photobiol B. 115, 63–72(2012)
  25. Interaction and photo–induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and  molecular docking study.  S. Tabassum, WM. Al–Asbahy, M. Afzal, F. Arjmand, RH. Khan, Mol Biosyst.;  8(9):2424–33. (2012)
  26. Synthesis of heterobimetallic complexes: in vitro DNA binding, cleavage and antimicrobial studies. S. Tabassum, M. Zaki, F. Arjmand, I. Ahmad, J Photochem Photobiol B.    3;114:108–18( 2012)
  27. Synthesis, characterization and interaction studies of copper based drug with Human Serum Albumin (HSA): spectroscopic and molecular docking      investigations. S. Tabassum, WM, Al–Asbahy, M. Afzal, F. Arjmand, J Photochem   Photobiol B. 114, 132 (2012)
  28. Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor. S. Tabassum, W. M. Al–Asbahy, M. Afzal, F. Arjmand, V. Bagchi, Dalton  Trans. 2012;41(16):4955–64.
  29. New modulated design and synthesis of chiral CuII/SnIV bimetallic potential anticancer drug entity: in vitro DNA binding and pBR322 DNA cleavage activity.           S. Tabassum, G. C. Sharma, F. Arjmand, Spectrochim Acta A Mol Biomol Spectrosc. 90, 208–17 (2012).
  30. Design, synthesis, characterization and DNA–binding studies of a triphenyltin(IV) complex of N–glycoside (GATPT), a sugar based apoptosis inducer: in vitro and  in vivo assessment of induction of apoptosis by GATPT.  S. Tabassum, S. Mathur, F. Arjmand, K. Mishra, K. Banerjee, Metallomics. 2012 ;4(2): 205–17.
  31. Chiral nano heterobimetallic DNA receptors: In vitro binding studies, cleavage activity and DNA condensation studies (TEM and AFM imaging), Sartaj Tabassum, Girish Chandra Sharma, Ahmad Asim, Ameer Azam, Rais Ahmad Khan, Journal of Organometallic Chemistry,  713, 2012,  123–133.
  32. DNA binding and cleavage studies of new sulfasalazine–derived dipeptide Zn(II) complex: Validation for specific recognition with 5′–TMP, Sartaj Tabassum, Waddhaah M. Al–Asbahy, Mohd. Afzal, Manal Shamsi, Farukh Arjmand, Journal of Luminescence,  132, 2012, 3058–3065.
  33. De novo design of chiral organotin cancer drug candidates: Validation of enantiopreferential binding to molecular target DNA and 5′–GMP by UV–visible, fluorescence, 1H and 31P NMR. Farukh Arjmand, Girish Chandra Sharma, Fatima Sayeed, Mohd. Muddassir, Sartaj Tabassum, Journal of Photochemistry and Photobiology B: Biology, 105, 2011, 167–174.
  34. Interaction of a ruthenium(II)–chalcone complex with double stranded DNA: Spectroscopic, molecular docking and nuclease properties, Ruchi Gaur, Rais Ahmad Khan Sartaj Tabassum, Priyanka Shah, Mohammad I. Siddiqi, Lallan Mishra, Journal of Photochemistry and Photobiology A:                Chemistry, 220, 2011,  145–152.
  35. Synthesis and characterization of glycoconjugate tin(IV) complexes: In vitro   DNA  binding studies, cytotoxicity, and cell death, Sartaj Tabassum, Rais Ahmad Khan, Farukh Arjmand, Subrata Sen, Jyoti Kayal, Aarti S. Juvekar, Surekha M. Zingde, Journal of Organometallic Chemistry, 696, 2011,  1600–1608.
  36. Carbohydrate–conjugate heterobimetallic complexes: synthesis, DNA binding studies, artificial nuclease activity and in vitro cytotoxicity. S. Tabassum, R. A. Khan, F. Arjmand M. Aziz, A. S. Juvekar, S. M. Zingde, Carbohydr Res. 346(18), 2886–95, 2011.
  37. Synthesis and enantiopreferential DNA–binding profile of late 3d transition metal  R–and S–enantiomeric complexes derived from N,N–bis–(1–benzyl–2–ethoxyethane): Validation of R–enantiomer of copper(II) complex as a        human opoisomerase II inhibitor. F. Arjmand, G. C. Sharma, M. Muddassir, S. Tabassum, Chirality.; 23(7), 557–67,                2011.
  38. Band gap narrowing and fluorescence properties of nickel doped SnO2 nanoparticles, Arham S.Ahmed, ShafeeqM.Muhamed, M.L.Singla, Sartaj Tabassum, Alim              H.Naqvi, AmeerAzam, Journal of Luminescence 131 (2011) 1–6.
  39. Synthesis of carbohydrate–conjugate heterobimetallic Cu(II)–Sn(2)(IV) and Zn(II)–Sn(2)(IV) complexes; their interactions with CT DNA and nucleotides; DNA cleavage, in–vitro cytotoxicity. S. Tabassum, R. A. Khan, F. Arjmand, A. S. Juvekar,  S. M. Zingde, Eur J  Med Chem. 45(11), 4797–806, 2010.
  40. Synthesis, structural and spectroscopic characterization and biomimetic properties of new copper, manganese, zinc complexes: Identification of possible superoxide–dismutase mimics bearing hydroxyl radical generating/ scavenging inabilities Giulio         Lupidi, Fabio Marchetti, Norberto Masciocchi, Daniel L. Rege, Sartaj Tabassum, Paola Astolfi, Elisabetta Damiani, Claudio Pettinari, J.  Inorg. Bio.Chem. 104, 820, 2010.
  41. DNA interaction studies of new nano metal based anticancer agent: validation by spectroscopic methods, Sartaj Tabassum, Girish Chandra Sharma, Farukh Arjmand and Ameer Azam, Nanotechnology 21, 195102–195112, 2010.
  42. Synthesis and characterization of glucose–bis (pyrazole)–Cu(II)/Ni(II) complexes    and their in vitro DNA binding studies Sartaj Tabassum and Irshad–ul–Haq Bhat, Chem. Pharm. Bull.; 58(3), 318–25, 2010.
  43. Synthesis of new heterobimetallic macromolecules, their DNA binding   cleavage studies, electrochemistry and in vitro electrochemotherapy study  Sartaj Tabassum, Irshad–ul–Haq Bhat and Farukh Arjmand Spectro chimica Acta Part A, 74, 1152 (2009).
  44. Synthesis of new piprazine derived Cu(II)/Zn(II) metal complexes, their DNA binding studies, electrochemistry and anti–microbial activity: Validation for         specific recognition of Zn(II) complex to DNA helix by interaction with thymine base. Irshad–ul–Haq Bhat and Sartaj Tabassum,  Spectro chimica Acta Part A: 72, 1026 (2009).
  45. Template synthesis of novel carboxamide dinuclear copper (II) complex: Spectral characterization and reactivity towards calf thymus DNA.  Suvigya Mathur and Sartaj Tabassum, Biometals, 21, 299 (2008).
  46. Identification of a Potent Inhibitor of Human Dual–Specific Phosphatase, VHR, from Computer–Aided and NMR–Based Screening to Cellular Effects. Zhe Shi, Sartaj Tabassum, Wei Jiang, Jiahai Zhang, Suvigya Mathur, Jihui Wu, Yunyu Shi Chem Bio Chem., 8, 2092 (2007).
  47. Cu(II) complexes as receptor molecules for development of new chloride sensors, Rakesh Kumar Mahajan, Ravneet Kaur, Sartaj Tabassum, Farukh Arjmand, Suvigya Mathur, Electrochimica Acta; 52, 408 (2006).
  48.   New homodi– and heterotrinuclear metal complexes of Schiff base compartment  ligand: interaction studies of copper complexes with calf thymus DNA. S. Mathur and S. Tabassum, Central European Journal of Chemistry; 4, 502                 (2006).
  49. Chemical and Biotechnological Developments in Organotin Cancer    Chemotherapy, S. Tabassum and C. Pettinari. Review J.Organometallics Chemistry; 691,1761 (2006).
  50. Synthesis and Characterization of a New Macrocyclic Copper (II) Complex Containing N–glycoside as a Pendant Arm: in vitro cytotoxicity and Binding Studies with Calf– Thymus DNA. S. Mathur and S. Tabassum, Chemistry and Biodiversity; 3, 312 (2006).
  51. Synthesis of O,O–ethylene bridged bis–copper(II) macrocycles: Selective enzyme models for catecholase activity, F. Arjmand, S. Parveen, M. Chauhan and S. Tabassum, Transition Met. Chem; 31, 237 (2006).
  52. Synthesis, Characterization, Solution Stability Studies,Electrochemistry and DNA Binding Behavior of Cu (II) Complexes of D–Gluconic acid. S. Tabassum and S. Mathur, J. Carbohydrate Chemistry; 24, 865 (2005).
  53. New modulated metallic macrocycles: Electrochemistry and their interaction with calf thymus DNA. S. Tabassum, S. Parveen and F. Arjmand, Acta Biomaterialia; 1, 677 (2005).
  54. Novel bimetallic complexes of copper, nickel and manganese derived from Cobalt (III) complex and their interaction studies with calf thymus DNA. S. Tabassum and I. H. Bhat, Transition. Met. Chem; 30, 998 (2005).
  55. Synthesis and characterization of new synthetic oxygen carriers. A kinetics study of the reaction of the binuclear iron(III)–copper(II) complex with H2O2. S. Tabassum, S. Parveen & F. Arjmand, Transition Met Chem; 30, 196 (2005).
  56. Synthesis of new dinuclear(II) and dinickel(II) complexes: Kinetics of catechol oxidase and electrochemistry of dicopper(II) complex. F. Arjmand, S. Parveen and S. Tabassum, Transition Met Chem; 30, 128 (2005).
  57. p53 dependent apoptotic mechanism of a new designer bimetallic compounds Triphenyl tin benimidazole copper chloride (TPTCuCl2): In vivo studies in wistar rats as well as in vitro studies in human cervical cancers cells. N. Hoti, De–e–Zhu, Z. Song, Z. Wu, S. Tabassum and M. Wu, J. Pharmacol Exp. Ther.(Jpet); 311, 22 (2004).
  58. New binuclear oxygen carriers of the type [M–mac–M’ (L)4]Cl2. (ClO4)2 where M–mac=Co(II) and Ni(II) 1,8–dihydro–1,3,6,8,10,13–hexaazacyclotetradecane, M’=Mn(II), Ni(II), Cu(II) and L= tetra(3–acetyl pyridine) and their kinetic studies with H2O2. S. Tabassum, S. Parveen and F. Arjmand, Indian J. Chem; 43A, 270 (2004).
  59. Triphenyl Tin Benzimidazolethiol, a Novel Antitumor Agent, Induces Mitochondrial– Mediated Apoptosis in Human Cervical Cancer Cells via Suppression of HPV–18 Encoded E6. N. Hoti, Jun Ma, S. Tabassum, Yi Wang and M. Wu, J. Biochem; 134, 521 (2003).  
  60. Synthesis and Characterization of the Copper(II) Complex with 2,2– bis(1H,3H,5H)Pyrimidine–4,6–dione–1,2–diiminoethane: Fluorescenc Quenching Studies in Proteins. S. Tabassum, N.P. Singh and J. Mussarat, Synth. React. Inorg. & Met.–org. Chem; 33, 509 (2003).
  61. Synthesis of New Five Coordinated Copper(II) and Nickel(II) Complexes of L– Valine and Kinetic Study of Copper(II) with Calf Thymus DNA. Tak, F. Arjmand and S. Tabassum, Metal Based Drugs; 9, 81 (2002).
  62. Synthesis of new metal compounds and their reactivity towards bovine milk casein. B.  Mohani, F.  Arjmand, S. Tabassum, Transition Met Chem; 27, 776 (2002).
  63. Synthesis, Characterization, Electrochemistry and Kinetics of CT DNA binding of  a bisciprofloxacin  borate copper(II) complex. A.A.  Tak, F.  Arjmand and  S. Tabassum, Transition Met Chem; 27, 741 (2002).
  64. Interaction of a new cobalt (II) complex of 5–coordinated chiral porphyrin with calf thymus DNA. S. Tabassum, F. Athar and F. Arjmand, Transition Met Chem; 27, 256 (2002).
  65. Synthesis, and characterization of novel macrocycles and their complexes with transition metal ions. S.Tabassum, S. H. Rafiqi and F. Arjmand, Synth. React. Inorg.Met–Org.                Chem; 32, 949 (2002).
  66. Synthesis, Characterization and Toxicity of Heterobinuclear complexes of transition Metal ions. S. Tabassum, N. P. Singh and F. Arjmand, Synth. React. Inorg. & met.      Org.       Chem; 31,1803 (2001).
  67. Novel asymmetric heterobimetallic complexes of transition metals and kinetics of oxygen binding to cobalt (II) complex. F. Athar, F.  Arjmand and S. Tabassum. Transition Met Chem; 26, 574   (2001).
  68. New asymmetric N2S2 macrocycles , their metal chelates and the Photokinetics of DNA–complex interaction. F. Athar, F. Arjmand and S. Tabassum, Transition Met Chem; 26, 426 (2001)
  69. Synthesis and Characterization of heterobimetallic Complexes of  1,8dihydro1,3,6,8,10,13 Hexaazacyclotetradecane with Cu (II), Ni(II), Si(IV), Ge(IV) and Sn(IV)         Chlorides. S.Tabassum, S.H.Rafiqi, N.Nishat, F.Arjmand and S. Srivastava            Indian. J.              Chem; 40(A), 1237 (2001).
  70. Synthesis and characterization of lanthanide chelates with metal containing ligands. S.Tabassum, A.Bashar, F.Arjmand, K.S. Siddiqi. Synth. React. InorgMet.Org.Chem; 27,487(1997).
  71. Reactivity of Sulpha drug metal complexs with group(IV) metal halides and some bioactive organic bases.  S. Tabassum, F. Arjmand, S.H. Rafiqi and Lutfullah. Main Group Metal Chemistry; 19, 245 (1996).
  72. Synthesis of new 14 and 16 membered macrocycles and their transition metalComplexes S. Tabassum, N. Nishat, F. Arjmand, Lutfullah and K.S. Siddiqi.    Transition Met Chem; 21, 97 (1996).
  73. Schiff base complexes as Ligand: Bimetallic Chelates of M (SB–H2)Cl2 with Group(IV)metal tetrachlorides, K.S. Siddiqi, F. Arjmand, S. Tabassum, and S.A.A. Zaidi, Synth. React.                Inorg. Met. Org. Chem; 25, 955 (1995).
  74. Chelating behaviour of new 12–membered Schiff base macrocycles containing pendant groups. S. Tabassum, N. Nishat, S.A.A. Zaidi and F. Arjmand, Transition Met Chem; 20, 13 (1995).
  75. An MCl2–moiety (M=copper, zinc, cadmium and mercury) stabilized by bis(ethylenediamine) copper(II) cation. Fathi M.A.M. Aqra, S. A. Shah, S. Tabassum, Rasheed M.A.Q Jamhour, K.S.          Siddiqi, Osama Al–Jowder and Fawzia Al–Saleh, Transition Met Chem; 20, 123 (1995).
  76. Heterobimetallic complexes of novel N2S2 macrocyclic ligands with Group IV tetrachlorides and bis(trimethylsilyl) amine. F. Arjmand, S. Tabassum, S.A.A. Zaidi      and K.S. Siddiqi. Main Group Metal Chemistry; 17 (1994).
  77. N2S2 Macrocyclic ligands: Synthesis and characterization of novel transition metal complexes of the type [LM(Si2Me6NH2)] and [LM(Si2Me6NH2)]. K.S. Siddiqi, F. Arjmand, S.Tabassum and S.A.A. Zaidi. Transition Met                 Chem; 19, 399 (1994).
  78. Novel heterobimetallic chelates: Condensation of (3–acetoacetyl–7 Cu (II) K.S.Siddiqi, F.Arjmand, Mujeeb–ur–Rehman, S.Tabassum and S.A.A. Zaidi. J. Chem. Research(s); 84(1994). J. Chem. Research (M); 03830393 (1994).
  79. Heterobimetallic chelates with 2–amino–3–formyl chromone. F. Arjmand, S. Tabassum, S.A.A. Zaidi and K.S. Siddiqi. Main Group Metal Chem 6,429 (1994).
  80. Equilibrium studies on interactions of rare earth ions with phytic acid. K.S. Siddiqi, S.A. Shah, F.M.A. Aqra, S. Tabassum and S.A.A.Zaidi. Indian J. Chem; 32A, 421 (1993).
  81. Lanthanide complexes of 2,2’–Bis–(1H, 3H, 5H)–pyrimidine–4,6–Dione–[1,3]– Diiminopropane and 2,2’–Bis–5, 5, Diethyl Pyrimidine (1H,3H)– pyrimidine–4,6–Dione[1,3]–Diiminopropane. K.S. Siddiqi, A. Bashar, S. Tabassum, F. Arjmand and S.A. A. Zaidi. Synth. React. Inorg. Met. Org. Chem; (1993).
  82. Complexes of Lanthanide (III) ions with an Schiff base derived from S benzoyl p–amino benzene sulphonamide dithiocarbamate and salicylaldehyde. S. Tabassum, F. Arjmand, K.S. Siddiqi, S.A.A. Zaidi and F. Caruso. Synth. React. Inorg. Met. Org. Chem; 23, 1425 (1993).
  83. Lanthanide metal chelates with bidentate Schiff base. K.S. Siddiqi, A. Bashar, S. Tabassum, S.A.A. Zaidi and N.I. Khan. Synth. React. Inorg. Met. Org. Chem; 22, 863 (1992).
  84. Synthesis and characterization of Transition metal complexes with 5–aminoinazolyl borates. K.S. Siddiqi, M.A. Neyazi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 30A, 724 (1991).
  85. Chelating behaviour of sulphadrug Schiff base towards lanthanide ions. K.S. Siddiqi, Abdul Bashar, S. Tabassum and S.A.A. Zaidi. Synth.React. Inorg. Met. Org. Chem; 21, 217(1991).
  86. Characterization, stability constants and toxicity of lanthanide complexes of Schiff base derived from sulphafurazole and thiophene–2 –aldehyde. K.S. Siddiqui, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 29A, 82 (1990).
  87. Physico–chemical and pesticidal activities on lanthanide complexes with Schiff   base derived from aldehyde and dithiocarbamate derivatives. K.S. Siddiqi, S. Tabassum, R.I. Kureshi, N.H. Khan, S.A.A. Zaidi and J. Casabo. Synth. React. Inorg. Met. Org. Chem; 20, 133 (1990).
  88. Synthesis, characterization and toxicity of complexes of 2,2– disubstitute thiazolidin–4–ones with group(IV) metal chlorides. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 28A, 83 (1989)
  89. Synthesis, characterization and toxicity of lanthanide complexes with Schiff bases derived from S–benzoyl dithiocarbazate and aldehydes. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A Zaidi. Indian J. Chem; 28A, 1074 (1989).
  90. Characterization and toxicity of lanthanide complexes with nitrogen and sulphur containing schiff bases. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Inorg. Chim. Acta; 15, 95 (1988).
  91. Synthesis and characterization of some group(IV) metal chloride complexes with 2,2–disubstituted–thioazolidine–4–ones. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and Z.A.A. Zaidi. Indian J. Chem; 26A, 763 (1987).
  92. Studies on barbituric acid complexes of lanthanide ions. S. Tabassum, K.S. Siddiqi, N.H. Khan, R.I. Kureshi and S.A.A. Zaidi. Indian J. Chem; 26A, 523 (1987).
  93. Complexes of some group (IV) metal ions with polymeric ligand derived from the condensation of salicylic acid thiourea and trioxane. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J.  Chem; 26A, 495(1987).
  94. Complexes of group(IV) metals with 5,5–’methylene bis (Salicylaldehyde) and its Schiff base with hydrazine. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 26A, 492 (1987).
  95. Studies on complexes of thiobarbituric acid and 5,5–diethyl–barbituric acid with lanthanide ions. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 26A, 489 (1987).
  96. Synthesis, characterization and toxicity of Group(IV) metal halide    dithiocarbamates,K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A.  Zaidi. Indian J. Chem; 26A, 70 (1987).
  97. Group (IV) metal halide chelates of salicyclic acid. Urea: Formaldehyde Copolymer.K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A. A.Zaidi Indian J. Chem; 24A, 68 (1985).
  98. Synthesis and characterization of Ge(IV), Sn(IV and Ti(IV) complexes of 5–aminoindazolyl dithiocarbamate. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 24A, 784 (1985).
  99. Characterization and toxicity of organotin(IV) halide complexes of cyclohexanone spirothiazolidinone and 2–Aminorhodanine. K.S. Siddiqi, N.H. Khan, R.I. Kureshi, S. Tabassum and S.A.A. Zaidi. Indian J. Chem; 24A, 954 (1985).

 

bioanalytical-techniques Flyer